Pioneering
 the Next-Generation
Immunotherapy We are pioneering a new paradigm in the treatment of autoimmune diseases Learn More From innovation
to healing
 We are shaping a healthier future worldwide through the development of immunotherapies Learn More Spreading
the Seed of Life
 We are cultivating science to deliver the fruits of hope. Learn More
About

WHO WE ARE

Grounded in scientific evidence and clinical experience, GBIOLOGICS creates patient‑centered innovation

Explore Our Vision

Beyond drug development, GBIOLOGICS leads the future of the global biopharmaceutical industry through strategic collaboration and innovation. Together with partners worldwide, we are shaping solutions for healthier lives.

Learn More

Meet Our Team

The leadership of GBIOLOGICS has grown on decades of deep expertise and unwavering dedication. Each member drives innovation with unique insight and integrity, built on extensive hands‑on experience.

Learn More

Inside Our Science

GBIOLOGICS is developing next‑generation autoimmune therapies using sGal‑9, a recombinant protein based on Galectin‑9, to restore immune balance. Through a fundamental approach of regulating bioactivity, we are opening the path to more profound treatments.

Learn More
About
About

sGalectin-9

The sGalectin‑9 platform of GBIOLOGICS specifically binds to glycated proteins in vivo, inducing diverse biological responses. Through this mechanism, it restores immune balance and surpasses the limited efficacy and side effects of existing therapies, paving the way for fundamental solutions to a wide range of autoimmune diseases.

AR is not supported on this device
About
clients

Latest News

Discover what’s new at GBIOLOGICS

clients

Work with Us

Together with all partners in medical innovation, GBIOLOGICS is opening the future of collaboration

Get-in-touch